Treating persistent depressive symptoms in post-ACS patients: the project COPES phase-I randomized controlled trial

Area of Science:

• Cardiology and Psychiatry
• Psychosocial aspects of cardiovascular disease

Background:

• Depression and sub-syndromal symptoms are significant predictors of morbidity and mortality post-acute coronary syndrome (ACS).
• Previous depression treatment trials in post-ACS patients showed no improvement in event-free survival and only modest symptom reduction.
• Key issues identified include optimal timing, patient acceptability, and safety of depression interventions in this population.

Purpose of the Study:

• To describe Project COPES (Coronary Psychosocial Evaluation Studies), a multi-center Phase-I randomized clinical trial.
• To evaluate patient preference depression treatment and a pre-randomization observation period for depression status.
• To inform subsequent clinical trials by providing data on patient satisfaction, treatment acceptability, symptom reduction, medication adherence, and inflammation.

Main Methods:

• A multi-center, Phase-I randomized clinical trial involving 200 post-ACS patients.
• Utilizes a patient preference depression treatment model.
• Includes a 3-month pre-randomization observation period to confirm depression status.

Main Results:

• Primary outcome: Patient satisfaction with depression care.
• Secondary, exploratory outcomes: Acceptability of depression treatment, reduction in depressive symptoms.
• Exploratory aims: Effects of treatment on medication adherence and inflammation as potential mediators linking depression to post-ACS prognosis.

Conclusions:

• Project COPES addresses critical issues in depression treatment for post-ACS patients, including timing, acceptability, and safety.
• The study prioritizes patient satisfaction and acceptability of depression care.
• Findings will guide the design of future, larger clinical trials investigating depression's impact on cardiovascular outcomes.